Human immunodeficiency virus‐associated neurocognitive disorders: Mind the gap
暂无分享,去创建一个
J. McArthur | N. Sacktor | A. Nath | J. Steiner | J. Mcarthur | Joseph P. Steiner | Avi Nath | Joseph Steiner | Avi Nath
[1] B. Ances,et al. Neurologic complications of HIV disease and their treatment. , 2010, Topics in HIV medicine : a publication of the International AIDS Society, USA.
[2] Jianhui Zhong,et al. Effects of Nadir Cd4 Count and Duration of Human Immunodeficiency Virus Infection on Brain Volumes in the Highly Active Antiretroviral Therapy Era , 2022 .
[3] R. Edelman,et al. Biomarkers of neurological status in HIV infection: A 3‐year study , 2010, Proteomics. Clinical applications.
[4] B. Gelman,et al. Persistent hijacking of brain proteasomes in HIV-associated dementia. , 2010, The American journal of pathology.
[5] S. Kongsaengdao. NEUROLOGIC IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME IN HIV/AIDS: OUTCOME AND EPIDEMIOLOGY , 2009, Neurology.
[6] Jean-Marie Annoni,et al. Cognitive dysfunction in HIV patients despite long-standing suppression of viremia , 2009, AIDS.
[7] G. Lopardo,et al. Good Neurocognitive Performance Measured by the International HIV Dementia Scale in Early HIV-1 Infection , 2009, Journal of acquired immune deficiency syndromes.
[8] B. Brew. HIV, the brain, children, HAART and 'neuro-HAART': a complex mix. , 2009, AIDS.
[9] F. Pereyra,et al. Persistent low-level viremia in HIV-1 elite controllers and relationship to immunologic parameters. , 2009, The Journal of infectious diseases.
[10] O. Laeyendecker,et al. HIV subtype D is associated with dementia, compared with subtype A, in immunosuppressed individuals at risk of cognitive impairment in Kampala, Uganda. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[11] C. Studholme,et al. Evidence for ongoing brain injury in human immunodeficiency virus-positive patients treated with antiretroviral therapy , 2009, Journal of NeuroVirology.
[12] B. Gelman,et al. Synaptic Proteins Linked to HIV-1 Infection and Immunoproteasome Induction: Proteomic Analysis of Human Synaptosomes , 2009, Journal of Neuroimmune Pharmacology.
[13] J. McArthur,et al. Serum matrix metalloproteinase levels correlate with brain injury in human immunodeficiency virus infection , 2009, Journal of NeuroVirology.
[14] F. Vaida,et al. Dynamics of cognitive change in impaired HIV-positive patients initiating antiretroviral therapy , 2009, Neurology.
[15] D. Clifford,et al. Impact of combination antiretroviral therapy on cerebrospinal fluid HIV RNA and neurocognitive performance , 2009, AIDS.
[16] R. Siliciano,et al. A Simian Immunodeficiency Virus-Infected Macaque Model To Study Viral Reservoirs That Persist during Highly Active Antiretroviral Therapy , 2009, Journal of Virology.
[17] Lucette A. Cysique,et al. Neurodegeneration and Ageing in the HAART Era , 2009, Journal of Neuroimmune Pharmacology.
[18] A. Zolopa,et al. Early Antiretroviral Therapy Reduces AIDS Progression/Death in Individuals with Acute Opportunistic Infections: A Multicenter Randomized Strategy Trial , 2009, PloS one.
[19] B. Brew. Faculty Opinions recommendation of PML-IRIS in patients with HIV infection: clinical manifestations and treatment with steroids. , 2009 .
[20] G. Fogel,et al. Extensive HIV-1 Intra-Host Recombination Is Common in Tissues with Abnormal Histopathology , 2009, PloS one.
[21] J. Fadel,et al. In vivo microdialysis in awake, freely moving rats demonstrates HIV‐1 Tat‐induced alterations in dopamine transmission , 2009, Synapse.
[22] D. Clifford,et al. Benefits and risks of stavudine therapy for HIV-associated neurologic complications in Uganda , 2009, Neurology.
[23] Fu-jie Zhang,et al. Human immunodeficiency virus and hepatitis C virus co-infection: epidemiology, natural history and the situation in China. , 2009, Chinese medical journal.
[24] R. Maizels,et al. Early recruitment of natural CD4+Foxp3+ Treg cells by infective larvae determines the outcome of filarial infection , 2009, European journal of immunology.
[25] B. Wigdahl,et al. HIV-1 Infection of Bone Marrow Hematopoietic Progenitor Cells and Their Role in Trafficking and Viral Dissemination , 2008, PLoS pathogens.
[26] K. Martemyanov,et al. Human Immunodeficiency Virus Protein Tat Induces Synapse Loss via a Reversible Process That Is Distinct from Cell Death , 2008, The Journal of Neuroscience.
[27] E. Masliah,et al. HIV-1 Tat Activates Neuronal Ryanodine Receptors with Rapid Induction of the Unfolded Protein Response and Mitochondrial Hyperpolarization , 2008, PloS one.
[28] J. Kipnis,et al. Immunity and cognition: what do age-related dementia, HIV-dementia and 'chemo-brain' have in common? , 2008, Trends in immunology.
[29] Dianne Langford,et al. HIV and antiretroviral therapy in the brain: neuronal injury and repair , 2008, Nature Reviews Neuroscience.
[30] Thomas Ernst,et al. Relative sensitivity of magnetic resonance spectroscopy and quantitative magnetic resonance imaging to cognitive function among nondemented individuals infected with HIV , 2008, Journal of the International Neuropsychological Society.
[31] J. Kipnis,et al. Adaptive immunity affects learning behavior in mice , 2008, Brain, Behavior, and Immunity.
[32] Steven Wolinsky,et al. Microbial Translocation Is Associated with Increased Monocyte Activation and Dementia in AIDS Patients , 2008, PloS one.
[33] N. Sacktor,et al. Developing neuroprotective strategies for treatment of HIV-associated neurocognitive dysfunction. , 2008, Future HIV therapy.
[34] Rebekah L. Gundry,et al. Nitrosative stress with HIV dementia causes decreased L-prostaglandin D synthase activity , 2008, Neurology.
[35] J. McArthur,et al. Converging roles for sphingolipids and cell stress in the progression of neuro-AIDS. , 2008, Frontiers in bioscience : a journal and virtual library.
[36] E. Freed,et al. Recent progress in antiretrovirals--lessons from resistance. , 2008, Drug discovery today.
[37] P. Seth,et al. Clade‐specific differences in neurotoxicity of human immunodeficiency virus‐1 B and C Tat of human neurons: significance of dicysteine C30C31 motif , 2008, Annals of neurology.
[38] D. Fuchs,et al. Persistent Intrathecal Immune Activation in HIV-1-Infected Individuals on Antiretroviral Therapy , 2008, Journal of acquired immune deficiency syndromes.
[39] A. Venkatesan,et al. Evolution of HIV dementia with HIV infection , 2008, International review of psychiatry.
[40] J. Bell,et al. The Neuropathology of HIV/AIDS , 2008, International review of psychiatry.
[41] B. Brew,et al. Biomarkers of HIV related central nervous system disease , 2008, International review of psychiatry.
[42] J. Margolick,et al. Longitudinally preserved psychomotor performance in long-term asymptomatic HIV-infected individuals , 2007, Neurology.
[43] J T Becker,et al. Biomarkers of HIV-1 CNS infection and injury , 2007, Neurology.
[44] P. Riederer,et al. Disruption of excitatory amino acid transporters in brains of SIV‐infected rhesus macaques is associated with microglia activation , 2007, Journal of neurochemistry.
[45] S. Lipton,et al. Memantine and HIV-associated cognitive impairment: a neuropsychological and proton magnetic resonance spectroscopy study , 2007, AIDS.
[46] Justin C McArthur,et al. The prevalence and incidence of neurocognitive impairment in the HAART era , 2007, AIDS.
[47] D. Clifford,et al. HIV-associated cognitive impairment in sub-Saharan Africa—the potential effect of clade diversity , 2007, Nature Clinical Practice Neurology.
[48] E. Masliah,et al. Pathogenesis of hepatitis C virus coinfection in the brains of patients infected with HIV. , 2007, The Journal of infectious diseases.
[49] N. McGrath,et al. FREQUENCY OF AND RISK FACTORS FOR HIV DEMENTIA IN AN HIV CLINIC IN SUB-SAHARAN AFRICA , 2007, Neurology.
[50] T. Burdo,et al. Osteopontin prevents monocyte recirculation and apoptosis , 2007, Journal of leukocyte biology.
[51] Amanda M. Brown,et al. In vitro modeling of the HIV‐macrophage reservoir , 2006, Journal of leukocyte biology.
[52] Caroline Anderson,et al. Oxidative stress and therapeutic approaches in HIV dementia. , 2006, Antioxidants & redox signaling.
[53] B. Gelman,et al. Abnormal Striatal Dopaminergic Synapses in National NeuroAIDS Tissue Consortium Subjects with HIV Encephalitis , 2006, Journal of Neuroimmune Pharmacology.
[54] D. Reich,et al. Immune reconstitution inflammatory syndrome in the CNS of HIV-infected patients , 2006, Neurology.
[55] M. Churchill,et al. Transcriptional activity of blood- and cerebrospinal fluid-derived nef/long-terminal repeat sequences isolated from a slow progressor infected with nef-deleted human immunodeficiency virus type 1 (HIV-1) who developed HIV-associated dementia , 2006, Journal of NeuroVirology.
[56] P. Calabresi,et al. Granzyme B mediates neurotoxicity through a G‐protein‐coupled receptor , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[57] P. Maruff,et al. Variable benefit in neuropsychological function in HIV-infected HAART-treated patients , 2006, Neurology.
[58] E. Masliah,et al. Cortical and subcortical neurodegeneration is associated with HIV neurocognitive impairment , 2006, AIDS.
[59] D. Simpson,et al. Effects of hepatic function and hepatitis C virus on the nervous system assessment of advanced-stage HIV-infected individuals , 2005, AIDS.
[60] I. Grant,et al. The effects of hepatitis C, HIV, and methamphetamine dependence on neuropsychological performance: biological correlates of disease , 2005, AIDS.
[61] T. Hassanein,et al. Neuropsychological test performance in patients co-infected with hepatitis C virus and HIV , 2005, AIDS.
[62] J. Clements,et al. Neuroprotective and anti-human immunodeficiency virus activity of minocycline. , 2005, JAMA.
[63] K. Marder,et al. Evaluation of HIV RNA and markers of immune activation as predictors of HIV-associated dementia , 2004, Neurology.
[64] J. McArthur,et al. Amyloid precursor protein expression in circulating monocytes and brain macrophages from patients with HIV-associated cognitive impairment , 2004, Journal of Neuroimmunology.
[65] M. Churchill,et al. Astrocyte specific viral strains in HIV dementia , 2004, Annals of neurology.
[66] J. McArthur. HIV dementia: an evolving disease , 2004, Journal of Neuroimmunology.
[67] Y. Liu,et al. Age, apolipoprotein E4, and the risk of HIV dementia: the Hawaii Aging with HIV Cohort , 2004, Journal of Neuroimmunology.
[68] K. Marder,et al. Attenuated central nervous system infection in advanced HIV/AIDS with combination antiretroviral therapy. , 2004, Archives of neurology.
[69] P. Maruff,et al. Antiretroviral therapy in HIV infection: are neurologically active drugs important? , 2004, Archives of neurology.
[70] A. Towfighi,et al. CSF soluble Fas correlates with the severity of HIV-associated dementia , 2004, Neurology.
[71] M. Mattson,et al. Perturbation of sphingolipid metabolism and ceramide production in HIV‐dementia , 2004, Annals of neurology.
[72] C. Overall,et al. HIV-induced metalloproteinase processing of the chemokine stromal cell derived factor-1 causes neurodegeneration , 2003, Nature Neuroscience.
[73] A. Nath,et al. Synaptic Transport of Human Immunodeficiency Virus-Tat Protein Causes Neurotoxicity and Gliosis in Rat Brain , 2003, The Journal of Neuroscience.
[74] A. d’Arminio Monforte,et al. Medication adherence among HIV+ adults: Effects of cognitive dysfunction and regimen complexity , 2003, Neurology.
[75] Bruce J Brew,et al. Marked improvement in survival following AIDS dementia complex in the era of highly active antiretroviral therapy , 2003, AIDS.
[76] C. Marra,et al. Changes in CSF and plasma HIV-1 RNA and cognition after starting potent antiretroviral therapy , 2003, Neurology.
[77] D. Butterfield,et al. Intracellular Human Immunodeficiency Virus Tat Expression in Astrocytes Promotes Astrocyte Survival but Induces Potent Neurotoxicity at Distant Sites via Axonal Transport* , 2003, The Journal of Biological Chemistry.
[78] E. Masliah,et al. Changing Patterns in the Neuropathogenesis of HIV During the HAART Era , 2003, Brain pathology.
[79] J. Bell,et al. Neuronal injury in hippocampus with human immunodeficiency virus transactivating protein, Tat , 2003, Neuroscience.
[80] S. Sánchez-Ramón,et al. Low blood CD8+ T-lymphocytes and high circulating monocytes are predictors of HIV-1-associated progressive encephalopathy in children. , 2003, Pediatrics.
[81] D. Butterfield,et al. Oxidative stress in HIV demented patients and protection ex vivo with novel antioxidants , 2003, Neurology.
[82] N. Sacktor. The epidemiology of human immunodeficiency virus-associated neurological disease in the era of highly active antiretroviral therapy. , 2002, Journal of neurovirology.
[83] E. Masliah,et al. Neurocognitive dysfunction predicts postmortem findings of HIV encephalitis , 2002, Neurology.
[84] B. Rovin,et al. HIV-1 infection and AIDS dementia are influenced by a mutant MCP-1 allele linked to increased monocyte infiltration of tissues and MCP-1 levels , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[85] P. Duca,et al. Pathological findings in the central nervous system of AIDS patients on assumed antiretroviral therapeutic regimens: retrospective study of 1597 autopsies , 2002, AIDS.
[86] B. Keele,et al. Follicular dendritic cell contributions to HIV pathogenesis. , 2002, Seminars in immunology.
[87] J. Balzarini,et al. Macrophages and HIV infection: therapeutical approaches toward this strategic virus reservoir. , 2002, Antiviral research.
[88] T. Jernigan,et al. Severe, demyelinating leukoencephalopathy in AIDS patients on antiretroviral therapy , 2002, AIDS.
[89] Y. Saeki,et al. Expression of osteopontin at sites of bone erosion in a murine experimental arthritis model of collagen-induced arthritis: possible involvement of osteopontin in bone destruction in arthritis. , 2002, Arthritis and rheumatism.
[90] T. Hassanein,et al. Neuropsychological impairment in patients with chronic hepatitis C , 2002, Hepatology.
[91] J. Allsop,et al. Hepatitis C and cognitive impairment in a cohort of patients with mild liver disease , 2002, Hepatology.
[92] Xavier Alvarez,et al. Central nervous system perivascular cells are immunoregulatory cells that connect the CNS with the peripheral immune system , 2001, Glia.
[93] J. Becker,et al. CSF antiretroviral drug penetrance and the treatment of HIV-associated psychomotor slowing , 2001, Neurology.
[94] J. Glass,et al. Increased frequency of the tumor necrosis factor‐α‐308 a allele in adults with human immunodeficiency virus dementia , 2001, Annals of neurology.
[95] J. Allsop,et al. Evidence for a cerebral effect of the hepatitis C virus , 2001, The Lancet.
[96] T. Jernigan,et al. Elevated cerebrospinal fluid quinolinic acid levels are associated with region-specific cerebral volume loss in HIV infection. , 2001, Brain : a journal of neurology.
[97] J. Catalan,et al. HIV-1 reverse transcriptase sequence in plasma and cerebrospinal fluid of patients with AIDS dementia complex treated with Abacavir , 2001, AIDS.
[98] A. Lazzarin,et al. Effect of genotypic resistance on the virological response to highly active antiretroviral therapy in cerebrospinal fluid. , 2001, AIDS research and human retroviruses.
[99] K. Marder,et al. Clinical trials in HIV-associated cognitive impairment: Cognitive and functional outcomes , 2001, Neurology.
[100] D. Corbett,et al. HIV‐1 Tat neurotoxicity is prevented by matrix metalloproteinase inhibitors , 2001, Annals of neurology.
[101] D. Cooper,et al. Evidence for independent development of resistance to HIV-1 reverse transcriptase inhibitors in the cerebrospinal fluid , 2000, AIDS.
[102] L. Sjulson,et al. Cytotoxicity by Matrix Metalloprotease-1 in Organotypic Spinal Cord and Dissociated Neuronal Cultures , 2000, Experimental Neurology.
[103] R. Steinman. DC-SIGN A Guide to Some Mysteries of Dendritic Cells , 2000, Cell.
[104] D. Clifford,et al. Human immunodeficiency virus-associated dementia. , 2000, Archives of neurology.
[105] A. Gamst,et al. Cerebrospinal fluid HIV RNA originates from both local CNS and systemic sources , 2000, Neurology.
[106] K. Marder,et al. Transdermal selegiline in HIV-associated cognitive impairment: Pilot, placebo-controlled study , 2000, Neurology.
[107] P. Narciso,et al. Positive and sustained effects of highly active antiretroviral therapy on HIV-1-associated neurocognitive impairment. , 1999, AIDS.
[108] E. Major,et al. Transient Exposure to HIV-1 Tat Protein Results in Cytokine Production in Macrophages and Astrocytes , 1999, The Journal of Biological Chemistry.
[109] E. Masliah,et al. Cortical Synaptic Density is Reduced in Mild to Moderate Human Immunodeficiency Virus Neurocognitive Disorder , 1999, Brain pathology.
[110] G. Fein,et al. Elevated subcortical choline metabolites in cognitively and clinically asymptomatic HIV patients , 1999, Neurology.
[111] J. Becker,et al. Plasma viral load and CD4 lymphocytes predict HIV-associated dementia and sensory neuropathy , 1999, Neurology.
[112] J. McArthur,et al. Rate and Severity of HIV-Associated Dementia (HAD): Correlations with Gp41 and iNOS , 1999, Molecular medicine.
[113] L. Chang,et al. Cerebral metabolite abnormalities correlate with clinical severity of HIV-1 cognitive motor complex , 1999, Neurology.
[114] R. Miller,et al. Chemokines regulate hippocampal neuronal signaling and gp120 neurotoxicity. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[115] B. Chesebro,et al. Neuronal Death Induced by Brain-Derived Human Immunodeficiency Virus Type 1 Envelope Genes Differs between Demented and Nondemented AIDS Patients , 1998, Journal of Virology.
[116] Lars Lannfelt,et al. HIV-infected subjects with the E4 allele for APOE have excess dementia and peripheral neuropathy , 1998, Nature Medicine.
[117] J. Sanes,et al. Synaptic laminin prevents glial entry into the synaptic cleft , 1998, Nature.
[118] E. Masliah,et al. Distribution of Brain HIV Load in AIDS , 1998, Brain pathology.
[119] Anne Casey,et al. Evidence for change , 1998 .
[120] C P Das,et al. Neurological complications of HIV infection. , 1998, Neurology India.
[121] Voon Wee Yong,et al. Matrix metalloproteinases and diseases of the CNS , 1998, Trends in Neurosciences.
[122] A. Nath,et al. Neurobiological aspects of human immunodeficiency virus infection:Neurotoxic mechanisms , 1998, Progress in Neurobiology.
[123] D. Roden,et al. The drug transporter P-glycoprotein limits oral absorption and brain entry of HIV-1 protease inhibitors. , 1998, The Journal of clinical investigation.
[124] D. Griffin,et al. Perspectives Series : Cytokines and the Brain Cytokines in the Brain during Viral Infection : Clues to HIV-associated Dementia , 1997 .
[125] E. Masliah,et al. Dendritic injury is a pathological substrate for human immunodeficiency virus—related cognitive disorders , 1997, Annals of neurology.
[126] J. McArthur,et al. Relationship between human immunodeficiency virus—associated dementia and viral load in cerebrospinal fluid and brain , 1997, Annals of neurology.
[127] J. Clements,et al. Pathogenesis of SIV encephalitis. Selection and replication of neurovirulent SIV. , 1997, The American journal of pathology.
[128] L. Eiden,et al. A Neuronal and Neuroanatomical Correlate of HIV‐1 Encephalopathy Relative to HIV‐1 Encephalitis in HIV‐1‐infected Children , 1997, Journal of neuropathology and experimental neurology.
[129] J. Glass,et al. Cellular localization of tumor necrosis factor mRNA in neurological tissue from HIV-infected patients by combined reverse transcriptase/polymerase chain reaction in situ hybridization and immunohistochemistry , 1997, Journal of Neuroimmunology.
[130] B. Brew,et al. Levels of human immunodeficiency virus type 1 RNA in cerebrospinal fluid correlate with AIDS dementia stage. , 1997, The Journal of infectious diseases.
[131] J. Sodroski,et al. CCR3 and CCR5 are co-receptors for HIV-1 infection of microglia , 1997, Nature.
[132] G. Rezza,et al. AIDS dementia complex in the Italian National AIDS Registry: temporal trends (1987–93) and differential incidence according to mode of transmission of HIV-1 infection , 1996, Journal of the Neurological Sciences.
[133] B. Premack,et al. Chemokine receptors: Gateways to inflammation and infection , 1996, Nature Medicine.
[134] J. Glass,et al. Localization of HIV‐1 in human brain using polymerase chain reaction/in situ hybridization and immunocytochemistry , 1996, Annals of neurology.
[135] M. Rosenblum,et al. AIDS dementia complex and HIV‐1 brain infection: Clinical‐virological correlations , 1995, Annals of neurology.
[136] K. Fowke,et al. Infection of Human Fetal Astrocytes with HIV‐1: Viral Tropism and the Role of Cell to Cell Contact in Viral Transmission , 1995, Journal of neuropathology and experimental neurology.
[137] P. Barker,et al. AIDS dementia complex: evaluation with proton MR spectroscopic imaging. , 1995, Radiology.
[138] A. Perelson,et al. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection , 1995, Nature.
[139] Y. Iwasaki,et al. HIV dementia , 1994, Neurology.
[140] A. Nath,et al. Characterization of a novel binding site for the human immunodeficiency virus type 1 envelope protein gp120 on human fetal astrocytes , 1994, Journal of virology.
[141] K. Marder,et al. Mortality risks in gay men with human immunodeficiency virus infection and cognitive impairment , 1993, Neurology.
[142] B. Chesebro,et al. Macrophage-tropic human immunodeficiency virus isolates from different patients exhibit unusual V3 envelope sequence homogeneity in comparison with T-cell-tropic isolates: definition of critical amino acids involved in cell tropism , 1992, Journal of virology.
[143] C. Achim,et al. Selective Neuronal Vulnerability in HIV Encephalitis , 1992, Journal of neuropathology and experimental neurology.
[144] E. Masliah,et al. Spectrum of human immunodeficiency virus–associated neocortical damage , 1992, Annals of neurology.
[145] R. Redfield,et al. Viral DNA and mRNA expression correlate with the stage of human immunodeficiency virus (HIV) type 1 infection in humans: evidence for viral replication in all stages of HIV disease , 1992, Journal of virology.
[146] D. Dickson,et al. Human immunodeficiency virus-1 infection of the nervous system: an autopsy study of 268 adult, pediatric, and fetal brains. , 1991, Human pathology.
[147] J. Sidtis,et al. Quinolinic acid in cerebrospinal fluid and serum in HIV‐1 Infection: Relationship to clinical and neurological status , 1991, Annals of neurology.
[148] R. Price,et al. Cerebrospinal fluid neopterin in human immunodeficiency virus type 1 infection , 1990, Annals of neurology.
[149] H. Budka,et al. Multifocal vacuolar leucoencephalopathy: a distinct HIV‐associated lesion of the brain ** , 1990, Neuropathology and applied neurobiology.
[150] J. Albert,et al. Biological characterization of paired human immunodeficiency virus type 1 isolates from blood and cerebrospinal fluid. , 1989, Virology.
[151] L. Epstein,et al. Elevated serum levels of tumor necrosis factor are associated with progressive encephalopathy in children with acquired immunodeficiency syndrome. , 1989, American journal of diseases of children.
[152] C. Boucher,et al. Persistent human immunodeficiency virus type 1 antigenemia in children correlates with disease progression. , 1988, Pediatrics.
[153] F. Mott,et al. Pathological Findings in the Central Nervous System of a Case of Myasthenia Gravis , 1924, Proceedings of the Royal Society of Medicine.
[154] B. Brew,et al. Quinolinic acid is produced by macrophages stimulated by platelet activating factor, Nef and Tat , 2011, Journal of NeuroVirology.
[155] B. Brew,et al. NeuroAIDS in the Asia Pacific Region , 2011, Journal of NeuroVirology.
[156] V. Valcour,et al. Aging exacerbates extrapyramidal motor signs in the era of highly active antiretroviral therapy , 2011, Journal of NeuroVirology.
[157] E. Masliah,et al. Relationship of antiretroviral treatment to postmortem brain tissue viral load in human immunodeficiency virus-infected patients , 2011, Journal of NeuroVirology.
[158] I. Grant,et al. Validation of the CNS Penetration-Effectiveness rank for quantifying antiretroviral penetration into the central nervous system. , 2008, Archives of neurology.
[159] K. Marder,et al. An evaluation of neurocognitive status and markers of immune activation as predictors of time to death in advanced HIV infection. , 2007, Archives of neurology.
[160] N. Nakasujja,et al. Human immunodeficiency virus neurological complications: an overview of the Ugandan experience. , 2005, Journal of neurovirology.
[161] H. Budka,et al. Loss of neurons in the frontal cortex in AIDS brains , 2004, Acta Neuropathologica.
[162] Bruce J Brew,et al. Evidence for a change in AIDS dementia complex in the era of highly active antiretroviral therapy and the possibility of new forms of AIDS dementia complex. , 2004, AIDS.
[163] W. Pardridge. Targeting neurotherapeutic agents through the blood-brain barrier. , 2002, Archives of neurology.
[164] K. Williams,et al. Central nervous system damage, monocytes and macrophages, and neurological disorders in AIDS. , 2002, Annual review of neuroscience.
[165] O. Selnes,et al. Improvement in HIV-associated motor slowing after antiretroviral therapy including protease inhibitors. , 2000, Journal of neurovirology.
[166] J. Clements,et al. SIV infection of macaques--modeling the progression to AIDS dementia. , 1998, Journal of neurovirology.
[167] G. Levi,et al. Virological and molecular parameters of HIV-1 infection of human embryonic astrocytes , 1998, Archives of Virology.
[168] P. Lantos,et al. Neuronal pattern correlates with the severity of human immunodeficiency virus-associated dementia complex. Usefulness of spatial pattern analysis in clinicopathological studies. , 1996, The American journal of pathology.
[169] J. Glass,et al. Human immunodeficiency virus and the brain. , 1996, Annual review of neuroscience.
[170] P. Lantos,et al. Assessment of neuronal density in the putamen in human immunodeficiency virus (HIV) infection. Application of stereology and spatial analysis of quadrats. , 1995, Journal of neurovirology.
[171] R. Price,et al. Cerebrospinal fluid beta 2 microglobulin in patients infected with human immunodeficiency virus. , 1989, Neurology.
[172] C. Cheng‐Mayer,et al. Distinct Biological Properties of Human and Serological , 2004 .